Dublin, Aug. 29, 2023 (GLOBE NEWSWIRE) -- The "Global Obesity Treatment Market (2023-2028) by Treatment and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
This report provides an extensive analysis of the Global Obesity Treatment Market. The market is estimated to be valued at USD 16.54 billion in 2023 and is projected to reach USD 26.44 billion by 2028, exhibiting a robust CAGR of 9.84%.
Obesity treatment encompasses a range of strategies, including lifestyle changes, behavioral therapy, counseling, medications, and bariatric surgery for severe cases. With sedentary lifestyles, poor dietary habits, and limited physical activity contributing to rising obesity rates, the demand for effective obesity treatments is increasing.
The prevalence of obesity is on the rise globally, cutting across all age groups, and is associated with an increased incidence of chronic diseases like type 2 diabetes, cardiovascular ailments, and certain cancers. Governments and healthcare providers recognize the urgency of addressing obesity and its related health issues, driving the need for impactful treatments and interventions.
As the burden of obesity-related diseases grows, healthcare spending is also increasing, creating opportunities for the obesity treatment industry. Governments and corporations are allocating more resources to combat the impact of obesity, offering a conducive environment for the growth of obesity treatment businesses. This trend supports the development and implementation of innovative therapies to manage and prevent obesity-related health problems.
Obesity is now acknowledged as a global health challenge, sparking increased research and development efforts in the field of obesity treatment. Companies in the pharmaceutical, biotechnology, and academic sectors are investing in novel treatments, drugs, and medical devices to address obesity effectively. As scientific understanding of obesity advances, businesses that offer innovative and scientifically validated solutions will find substantial market potential.
However, regulatory hurdles could present challenges for obesity treatment companies. Stringent approval processes and lengthy regulatory pathways can delay the introduction of new treatments, leading to higher costs and limited market access. This could potentially impede innovation and hinder timely patient access to new remedies.
Personalized obesity treatment is complicated due to the variability in individual responses to therapies, making it challenging to develop tailored and safe interventions. Continuous monitoring and specific interventions are necessary for optimal outcomes.
The report offers:
- Comprehensive evaluation of the Global Obesity Treatment Market
- In-depth qualitative analysis and verified data from credible sources
- Projections of market size using reliable research methodologies
- Excel data sheet for market size analysis
- Extensive primary and secondary research
- Analysis using Porter's 5 forces model, PESTLE Analysis, and the Ansoff Matrix
- Coverage of the impact of COVID-19 on the market
- Regulatory scenario overview across different geographies
- Self-Assessment Form for market positioning evaluation
- Customized research options with a 15% customization offer at no extra charge
Key report highlights:
- Thorough analysis of the parent industry
- Exploration of significant market dynamics and trends
- Comprehensive impact analysis to address risks and make strategic decisions
- Market segmentation insights
- Competitive analysis, including competitor comparison
- Historical, current, and projected market size in terms of value and volume
- Insights into market shares and strategies of key players
- Recommendations for enhancing market presence
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 203 |
| Forecast Period | 2023 - 2028 |
| Estimated Market Value (USD) in 2023 | $16.54 Billion |
| Forecasted Market Value (USD) by 2028 | $26.44 Billion |
| Compound Annual Growth Rate | 9.8% |
| Regions Covered | Global |
Market Dynamics
Drivers
- Rising Prevalence of Thalassemia
- Advancements in Diagnosis and Treatment in Innovation
Restraints
- High Cost of the Thalassemia Treatment
Opportunities
- Increasing Incidence of Beta-Thalassemia
- Current Trends in the Management of Beta Thalassemia
Challenges
- Lack of Voluntary Nonremunerated Blood Donors
Companies Mentioned
- AbbVie Inc.
- Apollo Endosurgery, Inc.
- Atkins Nutritional, Inc.
- BTL Aesthetics
- C.H. Boehringer Sohn AG & Co. KG
- Currax Pharmaceuticals LLC
- F. Hoffmann-La Roche, Ltd.
- Herbalife Ltd.
- Johnson & Johnson
- Kellogg Co.
- Mediflex Surgical Products
- Medtronic PLC
- Novo Nordisk A/S
- NutriSystem, Inc.
- Olympus Corp.
- Pfizer, Inc.
- Takeda Pharmaceuticals, Inc.
- Technogym S.p.A
- USGI Medical, Inc.
- Vivus, Inc.
Market Segmentation
The Global Obesity Treatment Market is segmented based on Treatment and Geography.
- By Treatment, the market is classified into Drugs and Surgery.
Drugs hold a larger market share. This is because drugs are becoming more widely accepted and accessible as a non-invasive therapy.
- By Geography, the market is classified into the Americas, Europe, Middle-East & Africa, and Asia-Pacific.
The Americas hold a significant market share. This is due to factors such as a higher prevalence of obesity, higher healthcare spending, and better access to modern medical treatments and interventions in the region.
For more information about this report visit https://www.researchandmarkets.com/r/g2qoqk
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
